Uroguanylin: How the gut got another satiety hormone

Journal of Clinical Investigation

Volumn 121, Issue 9, 2011, Pages 3384-3386

  Seeley, Randy J ^a   Tschöp, Matthias H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANYLATE CYCLASE; GUANYLIN; GUANYLYL CYCLASE 2C; HORMONE; UNCLASSIFIED DRUG; UROGUANYLIN;

BRAIN; FOOD INTAKE; HUMAN; INTESTINE; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; SATIETY;

ANIMALS; BEHAVIOR, ANIMAL; EATING; ENDOCRINE SYSTEM; FEEDING BEHAVIOR; FEMALE; MALE; NATRIURETIC PEPTIDES; RECEPTORS, GUANYLATE CYCLASE-COUPLED; RECEPTORS, PEPTIDE; SECOND MESSENGER SYSTEMS;

EID: 80052368587     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI58297     Document Type: Note

References (17)

1. Wren A.M. Gut and hormones and obesity. Front Horm Res. 2008;36:165-181.
2. Strader A.D., Woods S.C. Gastrointestinal hormones and food intake. Gastroenterology. 2005; 128(1):175-191. (Pubitemid 40039969)
3. Buchwald H., et al. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. Am J Med. 2009;122(3):248-256.
4. Thaler J.P., Cummings D.E. Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150(6):2518-2525.
5. Valentino M.A., et al. A uroguanylin-GUCY2C endocrine axis regulates feeding in mice. J Clin Invest. 2011;121(9):3578-3588.
6. Sindic A., Schlatter E. Renal electrolyte effects of guanylin and uroguanylin. Curr Opin Nephrol Hypertens. 2007;16(1):10-15. (Pubitemid 44885735)
7. Forte L.R. Jr. Uroguanylin and guanylin peptides: Pharmacology and experimental therapeutics. Pharmacol Ther. 2004;104(2):137-162.
8. You Y.J., Kim J., Raizen D.M., Avery L. Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: A model for satiety. Cell Metab. 2008;7(3):249-257. (Pubitemid 351285528)
9. Drucker D.J. The biology of incretin hormones. Cell Metab. 2006;3(3):153-165.
10. Renshaw D., Batterham R.L. Peptide YY: A potential therapy for obesity. Curr Drug Targets. 2005; 6(2):171-179. (Pubitemid 40394312)
11. Kirchner H., et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med. 2009;15(7):741-745.
12. Zhang J.V., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 2005;310(5750):996-999. (Pubitemid 41611907)
13. Kinzig K.P., et al. CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. J Neurosci. 2003;23(15):6163-6170. (Pubitemid 36875615)
14. Kinzig K.P., D'Alessio D.A., Seeley R.J. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci. 2002;22(23):10470-10476. (Pubitemid 35416883)
15. Chuang J.C., Zigman JM. Ghrelin's roles in stress, mood, and anxiety regulation. Int J Pept. 2010; 2010:460549.
16. Lutter M., et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci. 2008;11(7):752-753. (Pubitemid 351896679)
17. Tong J., et al. Ghrelin enhances olfactory sensitivity and exploratory sniffing in rodents and humans. J Neurosci. 2011;31(15):5841-5846.